HONG KONG (Reuters) – Innovent Biologics Inc has priced its Hong Kong initial public offering (IPO) near the top of its marketing range to raise $421 million, two people familiar with the matter said, …
( read original story …)
The HongKong News
HONG KONG (Reuters) – Innovent Biologics Inc has priced its Hong Kong initial public offering (IPO) near the top of its marketing range to raise $421 million, two people familiar with the matter said, …
( read original story …)